Table 2: Baseline clinical characteristics and associated mortality and opportunistic infections of HIV-infected patients in Jimma University specialized Hospital, between January 2006 to December 2011.

Characteristics	Number of patients[%]	Number of deaths[%]	Number of OI[%]
WHO clinical stage
Stage I	65[19.1]	6[14.3]	15[18.1]
Stage II	95[27.9]	9[21.4]	15[18.1]
Stage III	144[42.4]	17[40.5]	44[53.0]
Stage IV	36[10.6]	10[23.8]	9[10.8]
HAART regimen
Stavudine based	219[64.4]	19[45.2]	60[72.3]
Zidovudine based	72[21.2]	12[28.6]	18[21.7]
Tenofovir based	49[14.4]	11[26.2]	5[6.0]
Base line CD4
>350	5[1.5]	0[0.0]	2[2.4]
200-350	94[27.6]	7[16.7]	19[22.9]
100-199	139[40.9]	15[35.7]	37[44.6]
<100	102[30.0]	20[47.6]	25[30.1]
Risky behaviour
Yes	120[35.3]	14[33.3]	58[69.9]
No	220[64.7]	28[67.7]	25[30.1]
Cotrimoxazole Prophylaxis
Yes	330[97.1]	42[100.0]	81[97.6]
No Fluconazole Prophylaxis	10[2.9]	0[0.0]	2[2.4]
Yes	20[5.9]	8[19.1]	5[6.0]
No	320[94.1]	34[80.9]	78[94.0]]
INH prophylaxis
Yes	62[18.2]	7[16.7]	20[24.1]
No	278[81.8]	35[83.3]	63[75.9]